JFG
CATX icon

Jefferies Financial Group’s Perspective Therapeutics CATX Stock Holding History

Jefferies Financial Group’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-183,342
Closed -$765K – 1694
2026
Q1 		$765K Buy
+183,342
New +$775K 0.01% 1031
2024
Q2 		– Sell
-4,350
Closed -$51.8K – 1452
2024
Q1 		$51.8K Buy
+4,350
New +$37.1K ﹤0.01% 1491

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Jefferies Financial Group's CATX Position: Q2 2026 in Review

Jefferies Financial Group sold out of Perspective Therapeutics (CATX) in Q2 2026, closing a stake of 183,342 shares — an estimated $765K sold.

Jefferies Financial Group first reported a position in CATX in Q1 2024 and held it in 2 quarters. The position peaked at $765K in Q1 2026. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Jefferies Financial Group reported no remaining Perspective Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 183,342 Perspective Therapeutics shares in Q2 2026, an estimated $765K.
  • Jefferies Financial Group first reported a position in Perspective Therapeutics in Q1 2024 and held it in 2 quarters.
  • Jefferies Financial Group's Perspective Therapeutics position peaked at $765K in Q1 2026.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.